Research analysts covering FUJI PHOTO FILM CO LTD /FI.
Recent press releases and 8-K filings for FUJIY.
FUJIY: Biologics CDMO Market Projected to Reach USD 92.37 Billion by 2034
FUJIY
New Projects/Investments
Revenue Acceleration/Inflection
- The global biologics CDMO market is expected to grow from USD 21.96 billion in 2024 to USD 92.37 billion by 2034, demonstrating a strong CAGR of 15.45% between 2025 and 2034.
- This significant growth is primarily fueled by the increasing demand for monoclonal antibodies and biosimilars, a rise in biologics outsourcing, and rapid advancements in oncology and autoimmune therapies.
- North America led the market with a 36% share in 2024, while Asia-Pacific is anticipated to be the fastest-growing region during the forecast period.
- In 2024, mammalian manufacturing and monoclonal antibodies were the dominant segments, with biologics accounting for 61% of total revenue.
- The U.S. biologics CDMO market alone is valued at USD 6.39 billion in 2025 and is projected to exceed USD 23.60 billion by 2034, with a CAGR of 15.62% from 2025 to 2034.
Dec 15, 2025, 3:14 PM
Quarterly earnings call transcripts for FUJI PHOTO FILM CO LTD /FI.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more